Literature DB >> 22327227

Perioperative plasma F(2)-Isoprostane levels correlate with markers of impaired ventilation in infants with single-ventricle physiology undergoing stage 2 surgical palliation on the cardiopulmonary bypass.

Erin Albers1, Brian S Donahue, Ginger Milne, Benjamin R Saville, Wenli Wang, David Bichell, BethAnn McLaughlin.   

Abstract

Cardiopulmonary bypass (CPB) produces inflammation and oxidative stress, which contribute to postoperative complications after cardiac surgery. F(2)-Isoprostanes (F(2)-IsoPs) are products of lipid oxidative injury and represent the most accurate markers of oxidative stress. In adults undergoing cardiac surgery, CPB is associated with elevated IsoPs. The relationship between F(2)-IsoPs and perioperative end-organ function in infants with single-ventricle physiology, however, has not been well studied. This study prospectively enrolled 20 infants (ages 3-12 months) with univentricular physiology undergoing elective stage 2 palliation (bidirectional cavopulmonary anastomosis). Blood samples were collected before the surgical incision (T0), 30 min after initiation of CPB (T1), immediately after separation from CPB (T2), and 24 h postoperatively (T3). Plasma F(2)-IsoP levels were measured at each time point and correlated with indices of pulmonary function and other relevant clinical variables. Plasma F(2)-IsoPs increased significantly during surgery, with highest levels seen immediately after separation from CPB (p < 0.001). After separation from CPB, increased F(2)-IsoP was associated with lower arterial pH (ρ = -0.564; p = 0.012), higher partial pressure of carbon dioxide (PaCO(2); ρ = 0.633; p = 0.004), and decreased lung compliance (ρ = -0.783; p ≤ 0.001). After CPB, F(2)-IsoPs did not correlate with duration of CPB, arterial lactate, or immediate postoperative outcomes. In infants with single-ventricle physiology, CPB produces oxidative stress, as quantified by elevated F(2)-IsoP levels. Increased F(2)-IsoP levels correlated with impaired ventilation in the postoperative period. The extent to which F(2)-IsoPs and other bioactive products of lipid oxidative injury might predict or contribute to organ-specific stress warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22327227      PMCID: PMC3641818          DOI: 10.1007/s00246-012-0166-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  29 in total

1.  Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?

Authors:  M B Kadiiska; B C Gladen; D D Baird; D Germolec; L B Graham; C E Parker; A Nyska; J T Wachsman; B N Ames; S Basu; N Brot; G A Fitzgerald; R A Floyd; M George; J W Heinecke; G E Hatch; K Hensley; J A Lawson; L J Marnett; J D Morrow; D M Murray; J Plastaras; L J Roberts; J Rokach; M K Shigenaga; R S Sohal; J Sun; R R Tice; D H Van Thiel; D Wellner; P B Walter; K B Tomer; R P Mason; J C Barrett
Journal:  Free Radic Biol Med       Date:  2005-03-15       Impact factor: 7.376

Review 2.  Human biochemistry of the isoprostane pathway.

Authors:  Ginger L Milne; Huiyong Yin; Jason D Morrow
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

3.  Cytokine response in children undergoing surgery for congenital heart disease.

Authors:  Ashish B Madhok; Kaie Ojamaa; Viraga Haridas; Vincent A Parnell; Savita Pahwa; D Chowdhury
Journal:  Pediatr Cardiol       Date:  2006-07-06       Impact factor: 1.655

4.  Inhaled nitric oxide use in bidirectional Glenn anastomosis for elevated Glenn pressures.

Authors:  Hemant S Agarwal; Kevin B Churchwell; Thomas P Doyle; Karla G Christian; Davis C Drinkwater; Daniel W Byrne; Mary B Taylor
Journal:  Ann Thorac Surg       Date:  2006-04       Impact factor: 4.330

5.  Serologic markers of brain injury and cognitive function after cardiopulmonary bypass.

Authors:  Basel Ramlawi; James L Rudolph; Shigetoshi Mieno; Kamal Khabbaz; Neel R Sodha; Munir Boodhwani; Sue E Levkoff; Edward R Marcantonio; Frank W Sellke
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

6.  Quantification of F2-isoprostanes as a biomarker of oxidative stress.

Authors:  Ginger L Milne; Stephanie C Sanchez; Erik S Musiek; Jason D Morrow
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

7.  Oxidative stress precedes peak systemic inflammatory response in pediatric patients undergoing cardiopulmonary bypass operation.

Authors:  Stephan Christen; Barbara Finckh; Jens Lykkesfeldt; Peter Gessler; Manuela Frese-Schaper; Peter Nielsen; Edith R Schmid; Bernhard Schmitt
Journal:  Free Radic Biol Med       Date:  2005-05-15       Impact factor: 7.376

Review 8.  Isoprostanes and lung vascular pathology.

Authors:  Luke J Janssen
Journal:  Am J Respir Cell Mol Biol       Date:  2008-04-25       Impact factor: 6.914

9.  Oxidative stress and atrial fibrillation after cardiac surgery: a case-control study.

Authors:  Basel Ramlawi; Hasan Otu; Shigetoshi Mieno; Munir Boodhwani; Neel R Sodha; Richard T Clements; Cesario Bianchi; Frank W Sellke
Journal:  Ann Thorac Surg       Date:  2007-10       Impact factor: 4.330

Review 10.  Lung ischemia-reperfusion injury: implications of oxidative stress and platelet-arteriolar wall interactions.

Authors:  Alexander V Ovechkin; David Lominadze; Kara C Sedoris; Tonya W Robinson; Suresh C Tyagi; Andrew M Roberts
Journal:  Arch Physiol Biochem       Date:  2007-02       Impact factor: 4.076

View more
  6 in total

Review 1.  The isoprostanes--25 years later.

Authors:  Ginger L Milne; Qi Dai; L Jackson Roberts
Journal:  Biochim Biophys Acta       Date:  2014-10-30

2.  Acetaminophen attenuates lipid peroxidation in children undergoing cardiopulmonary bypass.

Authors:  Scott A Simpson; Hayden Zaccagni; David P Bichell; Karla G Christian; Bret A Mettler; Brian S Donahue; L Jackson Roberts; Mias Pretorius
Journal:  Pediatr Crit Care Med       Date:  2014-07       Impact factor: 3.624

3.  Perioperative intravenous acetaminophen attenuates lipid peroxidation in adults undergoing cardiopulmonary bypass: a randomized clinical trial.

Authors:  Frederic T Billings; Michael R Petracek; L Jackson Roberts; Mias Pretorius
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

Review 4.  The under reporting of recruitment strategies in research with children with life-threatening illnesses: A systematic review.

Authors:  Briony F Hudson; Linda Jm Oostendorp; Bridget Candy; Victoria Vickerstaff; Louise Jones; Monica Lakhanpaul; Myra Bluebond-Langner; Paddy Stone
Journal:  Palliat Med       Date:  2016-09-08       Impact factor: 4.762

5.  Enrichment of elevated plasma F2t-isoprostane levels in individuals with autism who are stratified by presence of gastrointestinal dysfunction.

Authors:  Phillip Gorrindo; Christianne Joy Lane; Evon Batey Lee; Bethann McLaughlin; Pat Levitt
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

Review 6.  Antioxidant Therapeutic Strategies for Cardiovascular Conditions Associated with Oxidative Stress.

Authors:  Jorge G Farías; Víctor M Molina; Rodrigo A Carrasco; Andrea B Zepeda; Elías Figueroa; Pablo Letelier; Rodrigo L Castillo
Journal:  Nutrients       Date:  2017-09-01       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.